Novo Nordisk cuts 13,000 jobs
1m
Novo Nordisk, the Danish maker of weight‑loss drugs, cut 13,000 jobs over the past year as it sought to reduce costs and broaden its business beyond obesity medicines.
STAT+: With new strategy, Novo outlines plans for obesity, direct-to-consumer work www.statnews.com/2026/09/21/n...
With new strategy, Novo outlines plans for obesity, direct-to-consumer work
Under investor pressure, Novo presented its strategy to both grow its obesity franchise and diversify its pipeline.
www.statnews.com
September 21, 2026 at 10:53 AM
STAT+: With new strategy, Novo outlines plans for obesity, direct-to-consumer work www.statnews.com/2026/09/21/n...